Md. Shah Amran

1.1k citations
75 papers · 712 indexed · h-index 13
Topics
Analytical Methods in Pharmaceuticals (10 papers)Natural Antidiabetic Agents Studies (7 papers)Drug-Induced Hepatotoxicity and Protection (7 papers)

In The Last Decade

Md. Shah Amran

66 papers receiving 663 citations

Peers

Md. Shah Amran
Comparison fields: 5 of 120
  • Molecular Biology 240
  • Pharmacology 86
  • Cardiology and Cardiovascular Medicine 84
  • Biomaterials 78
  • Physiology 76
Replace Abdul Wahab with:
Abdul Wahab Pakistan
Joanna Sikora Poland
Yiqiong Pu China
Ahmad Alhowail Saudi Arabia
Rohit Goyal India
Nengneng Cheng China
Lingyan Yu China
Radica Stepanović‐Petrović Serbia
Hongyan Qin China
Md. Shah Amran relative to Abdul Wahab Pakistan Abdul Wahab's profile →
Citations per field
00.5×3.7×
Abdul Wahab · 1×
Citations per year

Countries citing papers authored by Md. Shah Amran

Since Specialization
Citations

This map shows the geographic impact of Md. Shah Amran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Md. Shah Amran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Md. Shah Amran more than expected).

Fields of papers citing papers by Md. Shah Amran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Md. Shah Amran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Md. Shah Amran. The network helps show where Md. Shah Amran may publish in the future.

Co-authorship network of co-authors of Md. Shah Amran

This figure shows the co-authorship network connecting the top 25 collaborators of Md. Shah Amran. A scholar is included among the top collaborators of Md. Shah Amran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Md. Shah Amran. Md. Shah Amran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 2
5 4
6 0
7 1
8 41
9 2
10 1
11 11
12 5
13 15
14 1
15 14
16 45
17 2
18 1
19 3
20 11

About Md. Shah Amran

Md. Shah Amran is a scholar working on Pharmacology, Complementary and alternative medicine and Analytical Chemistry, having authored 75 papers that have together received 712 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (10 papers), Natural Antidiabetic Agents Studies (7 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). The work is most often cited by research in Pharmaceutical Science (59 citations), Pharmacology (62 citations) and Biomaterials (78 citations). Md. Shah Amran has collaborated with scholars based in Bangladesh, Saudi Arabia and Japan. Frequent co-authors include Keitaro Hashimoto, Md. Sahab Uddin, Md Shahid Sarwar, Abdullah Al Mamun, Ghulam Md Ashraf, Abu Asad Chowdhury, Maruf Ahmed, Shaila Kabir, Jakir Ahmed Chowdhury and Md. Nazir Hossen. Their work appears in journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026